It may be difficult for some New York business owners to envision goals for their company and how to achieve those goals. A crucial aspect, however, of the success of your business or business acquisition may be related to effectively setting goals and articulating how to reach those goals to realize the vision you had for your business.
Last week's blog discussed a local business merger which may have raised important questions concerning mergers and acquisitions and the process of buying a company. Companies are able to enjoy growth opportunities through mergers and acquisitions. For a merger or acquisition to be a positive growth opportunity for any company, however, the proper due diligence and research must be conducted. In addition, important legal ramifications and possible liabilities must also be carefully considered. The first step in acquiring or merging with a business is to determine which business is the best business for you and your company.
There have been a number of mergers and acquisitions announced recently in the technology field. A combined company valued at $40 billion is expected when chip maker NXP Semiconductors NV buys smaller chip maker Freescale Semiconductor Ltd. Freescale's value has been placed at $11.8 billion. The two companies plan to merge operations. The friendly acquisition deal was recently announced by the two companies.
Established private companies that are wishing to go public can often same significant time by using a reverse merger as opposed to making an initial public offering. An IPO can take months or years, while going public through a reverse merger can take as little as a few weeks.
Companies merge in order to achieve a variety of different results. Depending on the end goal, there are several different ways to categorize a merger.
In a move meant to increase the amount of branded pharmaceuticals it can offer, Endo International Plc has opted to acquire Auxilium Pharmaceuticals Inc. In New York, Auxilium's shares recently jumped 9 percent, and Endo's stock fell nearly 6 percent during the same period. Additionally, Auxilium's testosterone drugs, Testopel and Testim, will become part of Endo's offerings.
Investors and local residents may be interested in the latest news related to the proposed Comcast-Time Warner merger. Regulators in New York have chosen to delay their decision on the proposal until Nov. 13. The New York Public Service Commission was initially scheduled to review the deal on Oct 2. Without a mutually agreed-upon extension, transactions may automatically be granted if regulators fail to make a decision within the 120-day timed period mandated by federal law. However, Comcast and the commission agreed to delay the review in a filing dated Sept. 26.
In the past 10 years, Google has spent $23 billion in purchasing 145 companies. For the most part, these acquisitions have helped the company prosper and control various online content portals. According to many observers, one of the best investments that Google made was when it purchased YouTube for $1.65 billion in 2006. While some thought that the purchase price was high at the time, YouTube grossed $5.6 billion in 2013.
New York residents may be interested to learn how Walgreens recently decided against a lucrative business move. After facing pressure from activists and lawmakers, the company chose not to move its headquarters from the United States to Switzerland. The move overseas would have saved Walgreens an estimated $4 billion on its U.S. tax bill over the next five years.
Manhattan sports fans watched the World Cup in record numbers, resulting in a significant increase in pay-TV purchases. This was good news for major companies in the process of evaluating potential mergers.